期刊文献+

重组人Hsp70提呈的H22肝癌细胞混合抗原肽治疗小鼠肿瘤的研究 被引量:7

Experimental study on the therapy of murine tumor by mixed antigen peptides from H22 hepatocarcinoma cells presented by rhHsp70
原文传递
导出
摘要 目的 探讨H2 2肝癌细胞混合抗原肽体内抑制小鼠肿瘤的最佳方式。方法 采用冻融、低渗振荡、加热沉淀及酸处理等方法从H2 2肝癌细胞中制备抗原肽 ;将接种过H2 2瘤细胞的小鼠分别给予Hsp70 H2 2肽复合物注射、复合物 +pCH5 10质粒注射或化疗后给予复合物 +质粒注射 ,观察肿瘤抑制情况。结果 上述方法制备的抗原肽为混合肽 ,其与Hsp70形成的复合物体内能够抑制小鼠肿瘤生长 ,并且这种复合物可与pCH5 10质粒协同完全抑制 10 5接种的瘤细胞形成肿瘤 ,但不能完全抑制 10 6接种的瘤细胞形成肿瘤 ,然而这种双因素与化疗进行衔接则可完全抑制 10 6接种的瘤细胞形成肿瘤。结论 H2 2肝癌细胞肿瘤混合抗原肽经rhHsp70提呈可诱导H2 2荷瘤小鼠产生特异性免疫保护作用 。 Objective To study the inhibiting potentials of mixed antigen peptides from H22 hepatocarcinoma cells to murine tumor in vivo. Methods Using basic biochemical technique including freezing and thawing, hypotonic solution and vortexing, heating precipitation, acid precipitation and so on, the antigen peptides from H22 cells were obtained. The mice inoculated with H22 cells were injected with Hsp70-H22-peptides complex, Hsp70-H22-peptides complex+pCH510 plasmid, and the complex+the plasmid following chemotherapy respectively, and the inhibitory effect of different elements on tumor was observed. Results H22 antigen peptides was a kind of mixed peptides, capable of inhibiting the growth of tumor in vivo. Hsp70-H22 peptides complex with plasmid pCH510 completely inhibited the growth of tumor after inoculation of 10 5 H22 cells, but not by inoculation of 10 6 H22 cells. However, the growth of tumor after inoculation of 10 6 H22 cells was completely suppressed if the complex and the plasmid were used following chemotherapy. Conclusion H22 tumor-antigen peptides mixture can be presented by Hsp70 to induce specific immune protecting effect in mice bearing H22 carcinoma, and can be used in combination with other elements for efficacy.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2002年第2期160-163,共4页 Chinese Journal of Microbiology and Immunology
基金 国家自然科学基金资助项目 ( 39970 32 2 ) 教育部跨世纪人才培养计划基金资助项目
关键词 肿瘤 H22肝癌细胞 混合抗原肽 治疗 重组人Hsp70提呈 免疫疗法 H22 tumor mixed antigen peptides Hsp70-H22 peptide complex Tumor Inhibitory effect
  • 相关文献

参考文献2

二级参考文献5

共引文献9

同被引文献27

  • 1冯作化,李东,王洪涛,黄波,张桂梅.Investigation on the effect of peptides mixture from tumor cells inducing anti-tumor specific immune response[J].Science China(Life Sciences),2002,45(4):361-369. 被引量:12
  • 2Rosenberg RA. A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity, 1999.10:281-287.
  • 3Cahill DP, Lengauer C, Yu J, et al. Mutations of mitotic checkpoint genes in human cancers. Nature, 1998,392:300-303.
  • 4Srivastava PK, Menoret A, Basu B, et al. Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world.Immunity, 1998, 8:657-665.
  • 5Blachere NE, Li Z, Chandawarkar RY, et al. Heat shock proteinpeptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity, J Exp Med, 1997, 186:1315-1322.
  • 6Wang RF, Rosenberg SA. Human tumor antigens for cancer vaccine development, Immunol Rev, 1999,170:85-100.
  • 7Heiser A, Maurice MA, Yancey DR, et al. Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA. J Immunol, 2001,166:2953-2960.
  • 8Andersen MH, Pedersen LO, Capeller B, et al. Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients. Cancer Res, 2001,61 .5964-5968.
  • 9Nair SK, Heiser A, Boczkowski D, et al. Induction of cytotoxic T cell response and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. Nat Med, 2000,6:1011-1017.
  • 10Cignetti A, Guarini A, Gillio TA, et al. Interleukin-2 gene-transduced human leukemic cells induce major histocompatibility complex-restricted and-unrestricted anti-leukemic effectors in mixed lymphocyte-tumor cultures. Cancer Gene Ther, 2000,7:167-176.

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部